Healthcare stocks were moderately higher Tuesday afternoon, with
the NYSE Healthcare Sector Index rising about 0.1% and shares of
healthcare companies in the S&P 500 gaining around 0.6% as a
In company news, shares of Luminex Corp (
) rallied Tuesday after the biological testing company recorded Q1
earnings and revenue that blew by analyst estimates.
LMNX earned $0.24 per share during the three months ended March
31, excluding non-recurring items, beating the Capital IQ consensus
by $0.14. Revenue grew 6.4% over year-ago levels to $56.6 million,
beating the Street view by around $1.15 million.
The company also reaffirmed its FY14 outlook, expecting revenue
this year in a range of $225 million to $240 million, bracketing
the $230.14 million consensus.
LMNX shares were up just more than 20% at $19.11 each in mid-day
trade, easing slightly from its $19.56 session high. The stock has
a 52-week range of $15.39 to $24.10 a share, climbing 17.7% over
the past 12 months.
In other sector news,
(+) NVAX, (+13.1%) Announces positive top-line data from Phase
II testing of its respiratory syncytial virus vaccine candidate in
women of childbearing age, saying the drug was well-tolerated, with
no vaccine-related serious adverse events.
(-) QCOR, (-2.8%) Q1 EPS of $1.40 lags the Capital IQ consensus
estimate by $0.21 per share. Revenue rises 68.1% year over year to
$227.1 mln but still misses expectations by around $13.61 mln.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.